Current language:
- EN English
Refusal of a marketing authorisation for an anti-migraine medicine
Case opened
Case 364/2013/PMC - Opened on Tuesday | 19 March 2013 - Decision on Monday | 30 June 2014 - Institution concerned European Medicines Agency ( No maladministration found ) - Country United Kingdom
Allegation(s)
In formulating its position on the complainant's application for marketing authorisation, EMA made (i) procedural errors and (ii) manifest errors of appreciation.
Claim(s)
EMA should acknowledge its errors and inform the Commission accordingly.